Navigation Links
Introducing the Access Group and Its New Business Entities
Date:3/18/2011

l career experience, with more than 12 years of managed markets expertise in account management, training, and marketing.  Most recently with Boehringer Ingelheim Pharmaceuticals Inc. as Associate Director, Hypertension Franchise Marketing--Managed Markets for a leading antihypertensive agent

San Diego, California

MedAccess

  • Joseph Doyle, RPh, Senior Vice President, Business Development
    • Veteran executive with 30 years of global/US experience in strategy, management, marketing, advertising, and sales in the pharmaceutical, biotech, and medical technology industries, serving in senior leadership positions at GSW Worldwide, MedErgy HealthGroup, and 1Health Communications       
  • Gicell Schaenzler, Vice President, Client Strategy
    • More than 14 years of experience in strategic and tactical marketing and management, most recently as Vice President, Account Group Supervisor, for RCW McCann Healthcare, where she managed a key surgical product for obesity
  • Eric Schramm, Vice President, Group Account Supervisor
    • Former Account Group Supervisor at Regan Campbell Ward, a division of McCann – Erickson Healthcare Worldwide, with more than 11 years of experience in health care marketing and communications, including account management and strategic brand development

The Access Group

  • Michael Cirincione, Director of Finance
    • Former Corporate Accounting Manager at Dow Jones and Company, with more than 15 years of diversified corporate and divisional accounting experience

About the Access Group

The Access Group
'/>"/>

SOURCE The Access Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Introducing the next generation of chemical reactors
2. Varian Medical Systems Introducing OncoView(TM) - an Oncology Specific Image Management and Storage Solution
3. Pharmatech 2.0: Introducing Pharmatech Oncology
4. Introducing Sensitechs TempTale(R)4USB Temperature Monitor
5. Introducing deCODEme Cardio(TM) and deCODEme Cancer(TM)
6. Introducing the NEW Oakton pH 700 Benchtop Meter from Cole-Parmer
7. Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models for Use in Drug Discovery, Metabolism and Toxicology Studies, at The 49th Annual Meeting and ToxExpo In Salt Lake City, Utah, March 7-11, 2010, Booth #136
8. Access Pharmaceuticals to Present at the Noble Financial Equity Conference
9. Access Pharmaceuticals Licenses MuGard to Milestone Biosciences, LLC for North America
10. Mymetics Corporation Information to be Available Through Standard & Poors Market Access Program
11. GeoVax Labs, Inc. Information To Be Available Through Standard & Poors Market Access Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... treated and managed with the use of special anti-vascular endothelial growth factor agents ... many more patients, currently does not have a scientific protocol for the many ...
(Date:9/2/2015)... 2, 2015 Biovista Inc. is ... the 2015 BeHEARD science challenge, a global competition hosted ... researchers, access to the latest life science innovations and ... and pathway analytics capability to support Steven Laffoon ... the study of Niemann-Pick Disease Type A (NPA), a ...
(Date:9/2/2015)... , Sept. 2, 2015 Aytu BioScience, ... developing treatments for urological and related conditions, announced today ... planned private placement convertible note financing, raising a total ... tranches totaling $3.175 million. Josh ... from this private placement are intended to be used ...
(Date:9/2/2015)... , September 2, 2015 ... des Wettbewerbs BeHEARD von 2015 bekanntgeben zu können. ... Rare Genomics Institute. Biovista unterstützt mit ... für die Behandlung anderer Krankheiten als denen, für ... Laffoon und sein Team bei der Wylder ...
Breaking Biology Technology:StemCell GeneticMed Announces That It Has Started Stem Cell Treatments for Age Related Dry Macular Degeneration (AMG) 2Biovista Sponsors Wylder Nation Foundation's Research on Acid Sphingomyelinase Deficiency 2Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3Biovista sponsert die Forschung von Wylder Nation Foundation zum Thema Mangel an saurer Sphingomyelinase 2
... BRITISH COLUMBIA, Canada, Sept. 9 InNexus,Biotechnology Inc., ... a drug development company commercializing the next,generation of ... technology, welcomes David Warden to its Board of ... of Yetter, Warden & Coleman, L.L.P.,In his 23 ...
... mandate that workers exposed to flammable vapors or dusts be protected ... and Magnalight.com now has a significant offering of these lights available ... ... Dallas, TX (PRWEB) September 9, 2008 -- OSHA requirements ...
... 9 /Xinhua-PRNewswire-FirstCall/ --,China-Biotics, Inc. (OTC Bulletin Board: ... specializing in the manufacture,research, development, marketing and ... begun to install equipment for its new ... 789,000 square feet, is,located in Qing Pu ...
Cached Biology Technology:InNexus Biotechnology Strengthens Patent Team With New Leadership 2Explosion Proof Fluorescent Lights Keep Paint Spray Booths and Oil Rig Workers Safe 2China-Biotics, Inc. Provides Update on Construction of New Manufacturing Facility 2
(Date:8/26/2015)... 2015 The report "Multi-Factor Authentication (MFA) ... Application (Travel & Immigration, Government, Banking, Defense, Commercial Security, ... 2020", published by MarketsandMarkets, Multi-Factor Authentication Market is expected ... a CAGR of 17.7% between 2015 and 2020. ... igures spread through 169 P ages ...
(Date:8/20/2015)... Calif. , Aug. 20, 2015   ... focused on improving the user experience and security ... vision technologies, today announced that its TrulySecure™ ... biometric authentication software to be FIDO Certified™. ... TrulySecure for compliance with the FIDO UAF (Universal ...
(Date:8/17/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... mobile commerce market and creator of the Wocket® smart ... The new marketing campaign is being spearheaded by an ... ( http://amplitudemarketing.com/ ) and TPMG ( http://tmpg.com/ ). ... driven marketing and brand awareness and has a client ...
Breaking Biology News(10 mins):Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 2NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 3
... with the famous finches the Galpagos mockingbirds had a ... 176 years later, three of the four mockingbird species ... research published in BioMed Central,s open access journal BMC ... and provides information about their parasites to help ensure ...
... Most of the time, the immune system is the body,s ... lead to infection and disease. But in autoimmune diseases, ... body and attacking normal cells. A major discovery by ... of a previously unknown molecular interaction that is essential for ...
... in the October 2011 issue of Experimental Biology ... University Medical Center led by Stephen Tsang, MD, Ph.D ... mouse model for retinitis pigmentosa (RP) using novel bipartite ... characterized by progressive degeneration of rod photoreceptors (which mediate ...
Cached Biology News:A hitchhiker's guide to the Galápagos: co-evolution of Galápagos mockingbirds and their parasites 2La Jolla Institute discovers previously unknown cell interaction key in immune system attacks 2La Jolla Institute discovers previously unknown cell interaction key in immune system attacks 3Cell-specific mechanism-based gene therapy approach to treat retinitis pigmentosa 2Cell-specific mechanism-based gene therapy approach to treat retinitis pigmentosa 3
Human/Mouse/Rat LAR Affinity Purified PAb...
X-Gal, 100 mg. 5-Bromo-4-chloro-3-indolyl-b-d-galactoside.Histochemical substrate for b-galactosidase, used in blue/white screening.Store at -20 C. Protect from moisture. Category: Nucleotides & Enzy...
Human Jagged 2 Biotinylated Affinity Purified PAb...
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)...
Biology Products: